Class Action Lawsuit Filed Against Park Ha Biological Technology Co., Ltd.
Pomerantz Law Firm has filed a class action lawsuit against Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH), alleging securities fraud and market manipulation involving social media misinformation and impersonation of financial professionals. The firm claims that the company's stock price artificially surged from $4.00 at its IPO to an all-time high of $41.49 on July 7, 2025, without any legitimate business justification. Investors who purchased Park Ha securities during a specified class period are encouraged to contact Pomerantz LLP by September 28, 2026, to potentially be appointed as Lead Plaintiff in the case. The lawsuit suggests that fraudulent stock promotions were used immediately after the IPO to create an artificial buying frenzy among retail investors. Pomerantz is one of the leading firms specializing in corporate and securities litigation. It has a long history of recovering damages for victims of financial misconduct, including numerous multimillion-dollar settlements.
Topics: class action lawsuit market manipulation pump-and-dump scheme securities fraud